| 1 |
34025432 | Effects of Antiarrhythmic Drugs on hERG Gating in Human-Induced Pluripotent Stem Cell-Derived Cardiomyocytes From a Patient With Short QT Syndrome Type 1. | 2021 |
1 |
| 2 |
31049424 | Functional and pharmacological characterization of an S5 domain hERG mutation associated with short QT syndrome. | 2019 Apr |
1 |
| 3 |
30175559 | Action potential clamp characterization of the S631A hERG mutation associated with short QT syndrome. | 2018 Sep |
1 |
| 4 |
30481776 | A Heterozygous Missense hERG Mutation Associated with Early Repolarization Syndrome. | 2018 |
4 |
| 5 |
29085299 | Computational Analysis of the Mode of Action of Disopyramide and Quinidine on hERG-Linked Short QT Syndrome in Human Ventricles. | 2017 |
1 |
| 6 |
27690007 | Stereoselective Blockage of Quinidine and Quinine in the hERG Channel and the Effect of Their Rescue Potency on Drug-Induced hERG Trafficking Defect. | 2016 Sep 28 |
8 |
| 7 |
26867116 | How in vitro influences in silico utilized for the prediction of in vivo - pilot study of the drug-induced pro-arrhythmic potency prediction. | 2015 |
1 |
| 8 |
23103595 | Development of a high-throughput electrophysiological assay for the human ether-à-go-go related potassium channel hERG. | 2013 Jan-Feb |
1 |
| 9 |
24030418 | Screening drug-induced arrhythmia [corrected] using human induced pluripotent stem cell-derived cardiomyocytes and low-impedance microelectrode arrays. | 2013 Sep 10 |
1 |
| 10 |
24400172 | Modification by KCNE1 variants of the hERG potassium channel response to premature stimulation and to pharmacological inhibition. | 2013 Nov |
1 |
| 11 |
23300672 | Action potential clamp and pharmacology of the variant 1 Short QT Syndrome T618I hERG K⁺ channel. | 2012 |
3 |
| 12 |
22020101 | A mechanism underlying compound-induced voltage shift in the current activation of hERG by antiarrhythmic agents. | 2011 Nov 11 |
2 |
| 13 |
22028871 | Human engineered heart tissue as a versatile tool in basic research and preclinical toxicology. | 2011 |
1 |
| 14 |
20153443 | The action potential and comparative pharmacology of stem cell-derived human cardiomyocytes. | 2010 May-Jun |
1 |
| 15 |
18724381 | Pharmacology of the short QT syndrome N588K-hERG K+ channel mutation: differential impact on selected class I and class III antiarrhythmic drugs. | 2008 Nov |
1 |
| 16 |
17604185 | Action potential experiments complete hERG assay and QT-interval measurements in cardiac preclinical studies. | 2007 Sep-Oct |
2 |